Risk of Reinfection and Incidence of Chronic Symptoms After SARS-CoV-2 Infections.

IF 3.8 4区医学 Q2 IMMUNOLOGY

Open Forum Infectious Diseases Pub Date : 2024-10-15 eCollection Date: 2024-10-01 DOI:10.1093/ofid/ofae608

Liam Golding, Allison W Watts, Mark Pitblado, Felicity Clemens, Marina Viñeta Paramo, Jacob Shew, Michael A Irvine, Bahaa Abu-Raya, David M Goldfarb, Louise C Mâsse, Pascal M Lavoie

引用次数: 0

Abstract

This study showed that a severe acute respiratory syndrome coronavirus 2 infection reduced the risk of reinfection among vaccinated individuals by 0.50 (95% CI, 0.39-0.64) over a 1-year period, after accounting for unreported infections using avidity-based serology. Reciprocally, chronic symptoms increased from a baseline of 21% (95% CI, 16%-28%) among infection-naïve individuals to 43% (95% CI, 30%-61%) in reinfected individuals.

查看原文本刊更多论文

感染 SARS-CoV-2 后再感染的风险和慢性症状的发生率。

这项研究表明，在使用基于抗体的血清学方法计算未报告的感染后，严重急性呼吸系统综合征冠状病毒2感染可使接种疫苗者在1年内的再感染风险降低0.50（95% CI，0.39-0.64）。反过来，再感染者的慢性症状从基线的 21%（95% CI，16%-28%）增加到 43%（95% CI，30%-61%）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Open Forum Infectious Diseases Medicine-Neurology (clinical)

CiteScore

6.70

自引率

4.80%

发文量

630

审稿时长

9 weeks

期刊介绍： Open Forum Infectious Diseases provides a global forum for the publication of clinical, translational, and basic research findings in a fully open access, online journal environment. The journal reflects the broad diversity of the field of infectious diseases, and focuses on the intersection of biomedical science and clinical practice, with a particular emphasis on knowledge that holds the potential to improve patient care in populations around the world. Fully peer-reviewed, OFID supports the international community of infectious diseases experts by providing a venue for articles that further the understanding of all aspects of infectious diseases.